Skip to main content

Penny Daugherty, RN, MS, OCN, ONN-CG

Gynecologic Oncology Nurse Navigator
Northside Hospital Cancer Institute
Atlanta, GA

Authored Items

An Assessment of PARP Inhibitors in the Treatment of Recurrent Ovarian Cancer
By Penny Daugherty, RN, MS, OCN, ONN-CG
Rx Profiler The PARP Inhibitor Rucaparib in the Maintenance Therapy of Recurrent Ovarian Carcinoma: Highlights from the ARIEL3 Clinical Trial

Ovarian cancer is an avaricious tumor that can extend throughout the entire abdominal cavity. It is one of the most difficult diseases to diagnose and the most lethal gynecologic malignancy, being the fifth leading cause of cancer death in women in the United States.

Read More ›
An Assessment of PARP Inhibitors in the Treatment of Recurrent Ovarian Cancer
By Penny Daugherty, RN, MS, OCN, ONN-CG
Rx Profiler - The PARP Inhibitor Rucaparib in the Maintenance Therapy of Recurrent Ovarian Carcinoma: Highlights from the ARIEL3 Clinical Trial

Ovarian cancer is an avaricious tumor that can extend throughout the entire abdominal cavity. It is one of the most difficult diseases to diagnose and the most lethal gynecologic malignancy, being the fifth leading cause of cancer death in women in the United States.

Read More ›